The Neuroimaging Laboratories (NIL) at Washington University School of Medicine provides an interactive environment for a group of over 30 resident faculty and over 100 students, postdocs and staff. Housed within the Mallinckrodt Institute of Radiology, these investigators come from multiple WUSM Departments and collaborate with investigators across both WU campuses.
NIL investigators perform ground-breaking work in human cognitive and clinical neuroscience, human aging and neurodevelopment, human systems neuroscience, human neuropathophysiology, basic human brain physiology, and animal models of neurological disorders using neuroimaging techniques and analyses largely developed over the years in the NIL. Studies employ PET, MRI, TMS, Diffuse Optical Tomography (DOT) and EEG in conjunction with detailed behavioral analyses to understand the human and animal brain in health and disease.
The NIL has provided valuable support of many kinds for other large scale initiatives including the Human Connectome Project and Alzheimer Disease Research Center. As of 2013, NIL investigators had achieved an H index of 167 and were awarded over 15 million dollars in research funds in 2013.
The NIL provides a physical and intellectual environment that promotes collaborative, innovative and interdisciplinary neuroimaging research and supports the career development of students and junior faculty. In addition, there are extensive neuroimaging-specific computer services (through the Computer Support Group) and neuroinformatics support (through the NeuroInformatic Research Group).
Co-authorship network of NIL faculty based on papers from 2010-2011. Strong collaborations exist between NIL faculty members, across departments.
NIL faculty study a wide variety of normal and abnormal brain states across the life span. This graph illustrates the frequency of key words (larger font represents higher frequency) used in 993 manuscript titles from 2008-2012 published by NIL-associated faculty. Particular areas of emphasis include normal development and aging, Alzheimer's disease, schizophrenia, depression, stroke recovery, Parkinson's disease, dystonia and development disorders in young children.